23:24 Beijing time on October 5, 2021Teligent Inc New (TLGT.us)There was a change in the stock, and the share price fell rapidly by 5.13%. As of press time, the stock was trading at US $0.333 per share, with a turnover of 2.4605 million shares, a turnover rate of 2.65% and an amplitude of 7.04%.
Recent earnings data show that the stock achieved operating income of $10.43 million, net profit of-$12.87 million, earnings per share of-$0.14, gross profit of-$2.70 million and a price-earnings ratio of-0.05 times.
In terms of agency rating, there is currently no agency to make "buy, hold, sell" recommendations on the stock.
The pharmaceutical industry in which Teligent Inc New shares are located rose 1.06 per cent as a whole. Among its related stocksShineco, Inc. co., Ltd.、Clarus Therapeutics Hldgs Inc、REGENCELL BIOSCIENCE HLDGS LTDThe increase is relatively large.Sonoma Pharmaceuticals Inc, Teligent Inc New and Shineco, Inc. are more active, with turnover rates of 8.45%, 2.75% and 1.98% respectively.Alpha Teknova, Inc., Shineco, Inc. Company,Clarus Therapeutics Hldgs Inc C/Wts 11 + 08 * 2026 (To Pur Com)The amplitudes are 14.73%, 11.53% and 11.20%, respectively.
About Teligent Inc New: Teligent Inc is a professional generic drug company. Teligent develops, manufactures and markets (under its own trademark) local, injection, composite and ophthalmic pharmaceutical products in the United States and Canada. The product portfolio includes hospital-based sterile injections and topical medications (such as creams such as Synalar and Spectazole; lotions such as Kenalog; ointments such as Topicort and Kenalog; and topical drugs such as Pennsaid and Xylocaine). The company also serves the pharmaceutical, over-the-counter and cosmetics markets.
(the above content is completed by Money Call, a self-selected intelligent machine writer, and is only used as a reference for users to look at the market, not as a basis for transaction. )